CNTB Connect Biopharma Holdings Ltd
Company Analysis
Latest News
🟢 Connect Biopharma is trading 5.1% up today in after-hours trading on light liquidity
Connect Biopharma is trading at $2.25, up 5.1% in after-hours trading following a modest intraday pullback from recent pre-market strength. • The move appears...
🟢 Connect Biopharma is trading 5.9% up today on light pre-market liquidity and broader risk tone
Connect Biopharma is trading 5.9% up at $2.33 in pre-market on light liquidity and a positive risk tone, rebounding modestly after recent volatility around the...
🔴 Connect Biopharma is trading 10.1% down
Connect Biopharma is trading at $2.14, down 10.1% from a comparison close of $2.38 during regular trading. This is a price-action follow-up, so a separate...
🔴 Connect Biopharma is trading 6.7% down today in a pullback from recent technical momentum
Connect Biopharma is trading 6.7% down at $2.22 as the stock pulls back from a recent volatile run driven by technical momentum and prior positive analyst...
🟢 Connect Biopharma is trading 5.8% up today on technical momentum
Connect Biopharma is trading at $2.47 (5.8% up) as of July 17, 2026, on technical momentum despite a lack of fresh company filings or news. • The move follows...
Connect Biopharma Clears Its Nasdaq Hurdle — But Can a $90 Million Biotech Turn Compliance Into a Catalyst?
Shares surged as Connect Biopharma confirmed it has satisfied Nasdaq's minimum $1.00 bid-price rule, eliminating the threat of delisting that had dogged the...
🟢 Connect Biopharma Surges 17% Amid Positive Analyst Coverage and Clinical Progress
Connect Biopharma is trading 17% up at $2.75 in pre-market, primarily driven by recent positive analyst coverage and continued clinical progress for its lead...
🟢 Connect Biopharma is trading 10.7% up
Connect Biopharma is trading at $2.61, up 10.7% from a comparison close of $2.35 during after-hours. This is a price-action follow-up, so a separate catalyst...
🟢 Connect Biopharma is trading 5.7% up today on broad biotech sector strength and continued momentum
Connect Biopharma is trading at $2.49 (+5.73%) in after-hours trading, buoyed by a broad biotech sector bid and continued momentum. • No fresh...
🟢 Connect Biopharma is trading 11.9% up
Connect Biopharma is trading at $2.53, up 11.9% from a comparison close of $2.26 during regular trading. This is a price-action follow-up, so a separate...
🟢 Connect Biopharma is trading 6.86% up today in a rebound following a sharp selloff
Connect Biopharma is trading at $2.42 (+6.86%) in an apparent rebound following a significant decline in the previous session. • The stock is recovering from...
🔴 Connect Biopharma is trading 10.4% down
Connect Biopharma is trading at $2.25, down 10.4% from a comparison close of $2.51 during regular trading. This is a price-action follow-up, so a separate...
🔴 Connect Biopharma is trading 7.1% down today on profit-taking after sharp post-upgrade rally
Connect Biopharma is trading at $2.33 (7.1% down) as investors lock in gains following a sharp multi-day rally driven by bullish analyst sentiment. • The...
🟢 Connect Biopharma is trading 5.4% up today following positive analyst coverage and an $8 price target
Connect Biopharma is trading at $2.65 (up 5.4%) as the stock rebounds from a minor pullback, supported by a wave of bullish analyst sentiment. • Oppenheimer...
🔴 Connect Biopharma is trading 5.6% down today on profit-taking after recent rally
Connect Biopharma is trading 5.6% down at $2.51 today, likely reflecting profit-taking and consolidation following a sharp 19.8% gain on July 9. • The stock...
🟢 Connect Biopharma Holdings Ltd is trading 5.45% up
CNTB is trading at $2.81, up 5.45%.
🟢 Connect Biopharma is trading 13.5% up
Connect Biopharma is trading at $2.52, up 13.5% from a comparison close of $2.22 during regular trading. This is a price-action follow-up, so a separate...
Connect Biopharma Jumps 7% on Wall Street Cheerleading, but Can a $149 Million Company Really Take On Dupixent's $16 Billion Empire?
Shares of Connect Biopharma surged 7.2% to $2.38 as renewed analyst endorsements and anticipation around mid-2026 clinical data breathed life into a stock that...
🟢 Connect Biopharma is trading 7.2% up today on renewed analyst optimism and pipeline progress
Connect Biopharma is trading 7.2% up now at $2.38 following renewed analyst optimism and ongoing interest in its inflammatory disease pipeline. • Oppenheimer...
🟢 Connect Biopharma Holdings Ltd is trading 6.83% up in pre-market
CNTB is trading at $2.37, up 6.83% in pre-market.